Cancer, Advanced Recruiting Phase 1 Trials for Sapanisertib (DB11836)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Recruiting1 IdentifierTitlePurposeDrugs
NCT03017833Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory CancersTreatment